XClose

UCL Institute of Ophthalmology

Home
Menu
Dr Adam Dubis

Dr Adam Dubis

Associate Professor (Teaching) and Programme Lead Digital Health and Entrepreneurship

Global Business School for Health

Faculty of Pop Health Sciences

Joined UCL
1st Apr 2022

Research summary

Dr Adam Dubis is an enterprise minded educator, specialising in image and health data analysis. He started his career in the US, studying biology and chemistry, and participating in his university’s health entrepreneurship courses. Upon entering graduate school at the Medical College of Wisconsin, his background mixed with engineering resulting in commercialisation of several analytical tools and methods for ophthalmology. Moving to London in 2013, he has continued his enterprise activities consulting for a number of start-ups, as well as commercialising health analytics through patent filings and spin out companies. Since the beginning of my postgraduate work, my focus has always been on translating research from in silico to bedside. I have sought to continually build personal and team development tackling new challenging areas for myself and working in multidisciplinary teams to deliver successful outcomes through commercialisation of several devices and algorithms. These experiences taught me about the regulatory frameworks required for commercialisation in the medical technology space, and given my international placements, has also exposed me to how these vary across global markets.  

Teaching summary

UCL and the city of London are both amazing places, truly at the intersection of many different schools of thought. UCL has always prided itself on being transformational and positively disruptive. Launching of the first business school dedicated to health is only the first step in the process. The ability to be positively disruptive is something that I am keen to teach the first cohort students. Positively disruptive can take many different forms. The concept of making money from healthcare is met with mixed reviews globally. Being positively disruptive in thinking challenges this misconception, that business of health does not always need to be for making the most money, but rather about making the best care possible and knowing this will also equate to making positive contributions. 

 

In the digital health space, as well as the greater healthcare space there is something called the innovation abyss. This is used to describe the concept that there are ever increasing amounts of technology and other innovations being developed, however few traverse the abyss and to become implemented in a single healthcare system, let along globally transformational. However, there are strategies that can be implemented to improve the chances to traverse this abyss. Exploring these with the students is a second key area I am looking forward to teaching the first cohort of students.

Biography

My career to date has been a fortuitous journey from a desire to do medicine to a pursuit of academic research. As a first-year university student, I was required to design and complete simple experiments regarding cell metabolism and development. This sparked an interest in research that, over the following summer and two school years, led me to a research group looking to identify drug-able targets for common bacterial pathogens. At the Medical College of Wisconsin, PhD, introduced me to Prof Jay Neitz, who showed me I was colourblind, and hooked me on visual neuroscience. My PhD used commercial and custom built vision-testing devices to study structure/function/development of the human visual system. During my PhD, I had the oppurtunity to do a 1 year Marie Curie Fellowship in an applied optics group at the NUI-Galway. After my PhD, I went to the departments of Ophthalmology and Photonics at Duke University for a postdoctoral fellowship looking to integrate novel 3D imaging technology into a surgical microscope. After a great learning experience, I was given the opportunity to help build an imaging group to at UCL-IoO and MEH. From here, a dense network of translationally minded individuals allowed me to commercialisae several aspects of my research. As UCL launched their Global Business School for Health, seemed like a natural progression, so I joined the inaugural faculty and am heading up the digital health entrepreneurship programme.
Publications